BR0211545A - Método e composição para tratamento de hipertensão ocular e glaucoma - Google Patents

Método e composição para tratamento de hipertensão ocular e glaucoma

Info

Publication number
BR0211545A
BR0211545A BR0211545-0A BR0211545A BR0211545A BR 0211545 A BR0211545 A BR 0211545A BR 0211545 A BR0211545 A BR 0211545A BR 0211545 A BR0211545 A BR 0211545A
Authority
BR
Brazil
Prior art keywords
treatment
glaucoma
composition
ocular hypertension
present
Prior art date
Application number
BR0211545-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR0211545A publication Critical patent/BR0211545A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0211545-0A 2001-07-31 2002-07-30 Método e composição para tratamento de hipertensão ocular e glaucoma BR0211545A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30858901P 2001-07-31 2001-07-31
PCT/JP2002/007699 WO2003011299A2 (en) 2001-07-31 2002-07-30 Treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
BR0211545A true BR0211545A (pt) 2004-07-13

Family

ID=23194562

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211545-0A BR0211545A (pt) 2001-07-31 2002-07-30 Método e composição para tratamento de hipertensão ocular e glaucoma

Country Status (8)

Country Link
EP (1) EP1411950A2 (enExample)
JP (1) JP2004538306A (enExample)
KR (1) KR20040023707A (enExample)
CN (1) CN1646134A (enExample)
BR (1) BR0211545A (enExample)
CA (1) CA2454422A1 (enExample)
MX (1) MXPA04000980A (enExample)
WO (2) WO2003011299A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
BRPI0714709A2 (pt) * 2006-07-10 2013-02-26 Allergan Inc compostos terapÊuticos, bem como uso dos mesmos
DK2043993T3 (en) * 2006-07-11 2015-10-12 Allergan Inc Cyclopentane derivatives as anti-glaucoma agents
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
WO2009006370A1 (en) * 2007-07-03 2009-01-08 Allergan, Inc. Therapeutic substituted cyclopentanes for reducing intraocular pressure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580268B1 (en) * 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Ocular hypotensive agents
HUP0300391A3 (en) * 2000-03-16 2008-05-28 Sucampo Ag Use of prostaglandin related compounds for preparation of composition for use in treatment of ocular hypertension and glaucoma
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
MXPA04000980A (es) 2004-04-20
WO2003011299A2 (en) 2003-02-13
JP2004538306A (ja) 2004-12-24
WO2003011178A2 (en) 2003-02-13
KR20040023707A (ko) 2004-03-18
CA2454422A1 (en) 2003-02-13
WO2003011299A3 (en) 2003-10-30
CN1646134A (zh) 2005-07-27
EP1411950A2 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
ECSP034815A (es) "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas"
BR9712824A (pt) Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
BR0008059A (pt) Composições de valdecoxib
KR930001913A (ko) 안염 치료방법
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ES2090858T3 (es) Composicion que comprende una fuente de acido graso omega-3 y un estimulador de glutation para el tratamiento de trastornos inmunes e infecciones viricas.
CA2447924A1 (en) Olopatadine formulations for topical administration
BR9814923A (pt) Método para tratamento de doença de alzheimer
DK1676579T3 (da) Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea
BRPI0110914B8 (pt) 'composição farmacêutica líquida, processo para preparação da mesma e uso de uma composicão farmacêutica'
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
CA2502437A1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
BR9808016A (pt) Composições e métodos para redução da hipertensão ocular
BR9813811A (pt) "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo"
ATE227976T1 (de) Lösungen als träger für augenarzneien
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
KR960033452A (ko) 시신경 질환의 치료를 위한 프로스타노산 화합물
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
FI962493A0 (fi) Alfa-2-adrenoseptoriagonisteina käyttökelpoisia 6-(2-imidatsolinyyliamino)kinoksaliiniyhdisteitä
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
BR0012696A (pt) Composição oftálmica
BR0211545A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
BR0108219A (pt) Uso oftálmico de agentes bloqueadores alfa-adrenérgicos
DK1091733T3 (da) (-)-Pseudoephedrin som et sympatomimetisk lægemiddel
AU609807B2 (en) A composition for the topical treatment of glaucoma or ocular hypertension

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired